XML 27 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net loss $ (18,620,242) $ (19,514,977)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 240,175 248,154
Amortization of right-of-use assets 477,941 471,851
Realized and unrealized (gains) and losses, net, on investment securities (61,983) 34,302
Stock-based compensation 477,256 759,013
Realization of deferred income tax asset 1,280,385 286,641
Loss on extinguishment of debt 329,158
Write-off of note receivable (Transomic) 375,000
Amortization of deferred finance charges and debt discount associated with note payable 55,122
Net changes in:    
Accrued interest receivable on investment securities 68,136
Advances, deposits, and other current assets 408,859 (141,619)
Accounts payable and accrued liabilities (3,057,361) (1,992,929)
Net cash used in operating activities (18,854,970) (19,022,148)
Cash flows from investing activities:    
Purchases of investment securities (57,174) (13,541,806)
Proceeds from sale and maturity of investment securities 9,915,448 25,000,000
Purchases of property and equipment (29,541) (451,759)
Net cash provided by investing activities 9,828,733 11,006,435
Cash flows from financing activities:    
Proceeds from sale of common stock equity, net of issuance costs 9,060,438 2,781,438
Payoff of the SVB loan and accrued end-of-term fees (6,420,000)
Net cash (used in) provided by financing activities 9,060,438 (3,638,562)
Net change in cash, cash equivalents and restricted cash 34,201 (11,654,275)
Cash, cash equivalents and restricted cash at beginning of year 5,838,566 17,492,841
Cash and cash equivalents end of year 5,872,767 5,838,566
Supplemental disclosure of cash flow information:    
Interest 179,542
Non-Cash Investing and Financing Activities    
Recognition of right of use asset and liability $ 1,911,049